[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Wed, May 26th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Tue, May 25th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
[ Mon, May 24th 2021 ]: WOPRAI
Yigal Nochomovitz Initiated (SNDX) at Strong Buy and Held Target at $24 on, May 25th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Yigal Nochomovitz of Citigroup, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $24 on, May 25th, 2021.
Yigal has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, all agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $20 on, Wednesday, May 12th, 2021